Related Experiment Videos
Growth hormone and prolactin expression in the immune system
R Kooijman1, S Gerlo, A Coppens
1Department of Pharmacology, Medical School, Free University of Brussels, Laarbeeklaan 103, B-1090 Brussels, Belgium. rkooi@farc.vub.ac.be
Annals of the New York Academy of Sciences
|March 28, 2001
Summary
Human leukocytes produce high molecular-weight variants of prolactin (PRL) and growth hormone (GH). Certain leukemic myeloid cells secrete biologically active, pituitary-sized PRL, suggesting distinct roles in immune function.
Area of Science:
- Endocrinology
- Immunology
- Cell Biology
Background:
- Prolactin (PRL) and growth hormone (GH) are critical pituitary hormones involved in lactation and growth.
- Both PRL and GH are recognized as modulators of immune system responses.
- Leukocyte expression of GH and PRL suggests potential autocrine or paracrine functions in immunity.
Purpose of the Study:
- To investigate the production of PRL and GH within human leukocytes.
- To characterize the forms and biological activity of PRL and GH produced by immune cells.
Main Methods:
- Analysis of GH and PRL mRNA expression in human peripheral blood granulocytes.
- Detection and characterization of immunoreactive GH and PRL variants using molecular weight analysis.
- Assessment of biological activity using the Nb2 bioassay.
Main Results:
- Human peripheral blood granulocytes express GH and PRL mRNA.
- These granulocytes contain high molecular-weight variants (37 and 43 kDa) of GH and PRL, not pituitary-sized forms.
- No secretion of these variants or biologically active material was detected from granulocytes.
- Certain leukemic myeloid cells were found to secrete biologically active, 23-kDa pituitary-sized PRL.
Conclusions:
- Human granulocytes produce distinct, high molecular-weight variants of GH and PRL, but not the canonical pituitary forms.
- Leukemic myeloid cells can secrete biologically active, pituitary-sized PRL.
- These findings highlight differential production and potential distinct functions of PRL and GH in immune cells versus pituitary sources.